Different Predictors of Neurolgoical Worsening in Different Causes of Stroke
Arch Neurol 55:481-486, Yamamoto,H.,et al, 1998
Newer Concepts of Cerebral Vascular Disease
Med Clin North Am 54:1970., Meyer,J., 1970
Atherosclerotic CVD-Its Nature & Management
Am J Med 46:763, Heyden,S.,et al, 1969
Clinical Imaging Factors Associated with Infarct Progression in Patients with Ischemic Stroke During Transfer for Mechanical Thrombectomy
JAMA Neurol 74:1361-1367,1298, Boulouis, G.,et al, 2017
Deterioration of Giant Cell Arteritis With Corticosteroid Therapy
Arch Neurol 57:581-584, Staunton,H.,et al, 2000
Low Molecular Wt Heparinoid
ORG 10172 (Danaparoid) , & Outcome After Acute Ischemic Stroke, 10172 Acute Stroke Trtm (TOAST) Inve, t, JAMA 1272,1304,1998., 1998
Thromboendartectomy of the Symptomatic Occluded Internal Carotid Artery
J Neurosurg 76:752-758, McCormick,P.W.,et al, 1992
Antithrombotic Therapy in Cerebrovascular Disease
Ann Int Med 115:885-895, Rothrock,J.F.&Hart,R.G., 1991
Natural History of Progressive Ischemic Stroke in a Population Treated with Heparin
Stroke 21:1657-1662, Slivka,A.&Levy,D., 1990
An Alternative View of Heparin Anticoagulation in Acute Focal Brain Ischemia
Stroke 20:295-298, Phillips,S.J., 1989
Treatment of Acute Ischemic Stroke, Open Trial with Continuous Intravenous Heparinization
Arch Neurol 43:386-390, Ramirez-Lassepas,M.,et al, 1986
Evaluation of Acute Cerebral Ischemia for Anticoag Therapy:CT or Lumbar Puncture
Neurol 31:736-740, Ruff,R.L.,et al, 1981